Emami approves ₹282 crore open-market buyback at up to ₹475 a share

Kolkata-based FMCG maker Emami will buy back up to 59.37 lakh shares, or 1.36% of paid-up equity, with minimum utilisation of ₹211.5 crore. The decision follows Q1FY27 revenue growth of 15% to ₹1,039.21 crore, while net profit fell 15% to ₹138.94 crore amid higher West Asia-linked input costs.

— Source publishedThu, 17 Sept, 2026, 20:19 IST·First seen Thu, 17 Sept, 2026, 20:23 IST·Source The Hindu BusinessLine

What happened

Emami approved an open-market share buyback of up to ₹282 crore at ₹475 per share. The Kolkata FMCG maker also reported Q1FY27 profit fell 15% to ₹138.94 crore

Key facts

  • ₹282 crore maximum buyback size
  • ₹475 maximum price per equity share
  • 59.37 lakh shares maximum, representing 1.36% of paid-up equity capital
  • ₹211.50 crore minimum buyback utilisation
  • ₹112.80 crore to be utilised in the initial first half of the offer
  • Q1FY27 net profit ₹138.94 crore, down 15% YoY
  • Q1FY27 revenue ₹1,039.21 crore, up 15% YoY

Why this matters

Emami’s decision to deploy up to ₹282 crore on a buyback prioritises shareholder returns over near-term inorganic expansion, while its input-cost pressure could make supply-chain or category adjacencies strategically relevant.

What to watch

  • Actual buyback execution price and pace relative to the ₹475 ceiling and ₹211.5 crore minimum utilisation.
  • Quarterly gross-margin trend, especially raw-material, packaging and freight costs linked to West Asia.
  • Whether revenue growth remains double digit after pricing actions, particularly in core domestic brands and rural markets.
  • Q2/Q3 net-profit recovery, EBITDA-margin movement and management commentary on commodity hedging or price hikes.
  • Promoter and institutional shareholding changes after the buyback, which could affect free float and trading liquidity.
  • Begin the tender/open-market execution process within regulatory timelines and disclose periodic buyback progress.
  • Prioritize price increases, pack-size adjustments and sourcing actions to defend gross margin in personal care and healthcare categories.
  • Maintain advertising and distribution investment selectively to preserve the 15% revenue-growth momentum without materially worsening operating leverage.
  • Potentially increase communication around cash generation, promoter participation restrictions and post-buyback capital-allocation priorities.